FLUTICASONE PROPIONATE NASAL

FLUTICASONE PROPIONATE NASAL was reported 30999 times

FLUTICASONE PROPIONATE NASAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 91 0.3003
1 SALPINGO-OOPHORECTOMY UNILATERAL 25 0.2273
2 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 31 0.1732
3 APPENDICOLITH 40 0.1034
4 ADRENAL SUPPRESSION 75 0.0890
5 CARDIOSPASM 44 0.0789
6 EPIDURAL LIPOMATOSIS 27 0.0785
7 TEMPERATURE REGULATION DISORDER 174 0.0780
8 FEMALE GENITAL TRACT FISTULA 129 0.0755
9 CUSHING'S SYNDROME 49 0.0705
10 IMMUNISATION 29 0.0668
11 MITE ALLERGY 43 0.0656
12 MULTIPLE DRUG THERAPY 45 0.0597
13 PALMOPLANTAR KERATODERMA 43 0.0593
14 CHRONIC SINUSITIS 208 0.0554
15 INFUSION SITE DISCHARGE 97 0.0553
16 PRODUCT DELIVERY MECHANISM ISSUE 270 0.0502
17 EOSINOPHIL COUNT ABNORMAL 35 0.0469
18 OBSTRUCTIVE SLEEP APNOEA SYNDROME 66 0.0452
19 PULMONARY VASCULITIS 24 0.0446
20 FOOD ALLERGY 340 0.0440
21 SPIROMETRY ABNORMAL 26 0.0435
22 ALLERGIC GRANULOMATOUS ANGIITIS 35 0.0426
23 BLOOD CORTISOL DECREASED 27 0.0422
24 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 85 0.0416
25 NASAL OEDEMA 74 0.0409
26 SINUSITIS FUNGAL 32 0.0399
27 MYCOTIC ALLERGY 34 0.0398
28 DEVICE MAINTENANCE ISSUE 23 0.0391
29 RADICULOPATHY 100 0.0379
30 DUST ALLERGY 37 0.0377
31 INFUSION SITE MASS 40 0.0368
32 INFUSION SITE REACTION 109 0.0365
33 INFUSION SITE HAEMORRHAGE 111 0.0337
34 PROCTITIS 92 0.0328
35 FOETAL DEATH 168 0.0324
36 NASAL DISCHARGE DISCOLOURATION 44 0.0319
37 PERIPHERAL VENOUS DISEASE 128 0.0313
38 INFUSION SITE BRUISING 66 0.0305
39 SPUTUM INCREASED 66 0.0305
40 RESPIRATORY SYMPTOM 86 0.0302
41 FACET JOINT SYNDROME 98 0.0301
42 INFUSION SITE PRURITUS 91 0.0288
43 BRONCHIAL HYPERREACTIVITY 34 0.0283
44 LUPUS VULGARIS 34 0.0270
45 ONYCHOMADESIS 108 0.0257
46 RHEUMATIC FEVER 111 0.0249
47 CONJUNCTIVITIS ALLERGIC 36 0.0243
48 INFUSION SITE IRRITATION 31 0.0241
49 RESTRICTIVE PULMONARY DISEASE 28 0.0239
50 SEASONAL ALLERGY 337 0.0238
51 ACUTE SINUSITIS 39 0.0226
52 BLEPHAROSPASM 142 0.0225
53 BURSITIS 271 0.0223
54 MYOGLOBIN BLOOD INCREASED 34 0.0222
55 INFUSION SITE INFECTION 51 0.0219
56 ATRIAL TACHYCARDIA 46 0.0219
57 DEVICE INFUSION ISSUE 53 0.0214
58 INFUSION SITE WARMTH 26 0.0212
59 MACULAR DEGENERATION 252 0.0211
60 RHINALGIA 57 0.0207
61 MULTIPLE ALLERGIES 161 0.0205
62 IMMUNODEFICIENCY 306 0.0205
63 INFUSION SITE SWELLING 129 0.0205
64 NASAL DISCOMFORT 158 0.0199
65 OBSTRUCTIVE AIRWAYS DISORDER 217 0.0195
66 NASAL POLYPS 96 0.0195
67 INFUSION SITE PAIN 251 0.0195
68 ESSENTIAL HYPERTENSION 35 0.0191
69 PRURITUS GENITAL 45 0.0191
70 CUSHINGOID 61 0.0190
71 UPPER-AIRWAY COUGH SYNDROME 156 0.0189
72 INFUSION SITE ERYTHEMA 157 0.0186
73 SECONDARY ADRENOCORTICAL INSUFFICIENCY 28 0.0185
74 MULTI-ORGAN DISORDER 36 0.0183
75 ASTHMATIC CRISIS 65 0.0178
76 TERMINAL INSOMNIA 31 0.0175
77 COELIAC DISEASE 171 0.0174
78 BREAST CANCER STAGE III 112 0.0173
79 INFUSION SITE INDURATION 25 0.0169
80 RETINITIS 29 0.0168
81 HYPERPHOSPHATAEMIA 36 0.0167
82 FORCED EXPIRATORY VOLUME DECREASED 47 0.0166
83 PRESCRIBED OVERDOSE 321 0.0166
84 ADRENOCORTICAL INSUFFICIENCY ACUTE 32 0.0164
85 NEURITIS 25 0.0162
86 BLOOD PHOSPHORUS INCREASED 44 0.0161
87 PRODUCT ADMINISTRATION INTERRUPTED 125 0.0159
88 DISLOCATION OF VERTEBRA 35 0.0153
89 PRE-EXISTING CONDITION IMPROVED 93 0.0149
90 ASTHMA 1682 0.0149
91 EYELID PAIN 30 0.0147
92 DUODENAL ULCER PERFORATION 106 0.0142
93 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 102 0.0142
94 INCREASED UPPER AIRWAY SECRETION 73 0.0142
95 X-RAY ABNORMAL 25 0.0140
96 NASAL SEPTUM DEVIATION 27 0.0138
97 WHEEZING 815 0.0137
98 BLOOD IMMUNOGLOBULIN E INCREASED 33 0.0136
99 EMBOLISM VENOUS 41 0.0135
100 CAROTID ARTERY OCCLUSION 49 0.0134
101 FULL BLOOD COUNT ABNORMAL 142 0.0134
102 UPPER RESPIRATORY TRACT INFECTION 615 0.0133
103 DIASTOLIC DYSFUNCTION 41 0.0133
104 RHINITIS ALLERGIC 59 0.0132
105 RHINITIS 106 0.0131
106 SLEEP TERROR 55 0.0130
107 EXERCISE TOLERANCE DECREASED 75 0.0130
108 BONE EROSION 46 0.0130
109 DEEP VEIN THROMBOSIS POSTOPERATIVE 26 0.0130
110 ANOSMIA 188 0.0130
111 PARANASAL SINUS DISCOMFORT 49 0.0129
112 BACK INJURY 138 0.0127
113 TENOSYNOVITIS 35 0.0127
114 ORAL CANDIDIASIS 164 0.0124
115 BRAIN NATRIURETIC PEPTIDE INCREASED 37 0.0120
116 PLANTAR FASCIITIS 40 0.0119
117 TENSION HEADACHE 51 0.0118
118 MIDDLE EAR EFFUSION 26 0.0118
119 RESPIRATORY TRACT INFECTION 304 0.0117
120 NASAL DRYNESS 73 0.0116
121 LIVE BIRTH 97 0.0116
122 SINUS PAIN 27 0.0116
123 DRUG TOLERANCE DECREASED 32 0.0114
124 WOUND INFECTION 124 0.0113
125 NASAL DISORDER 30 0.0113
126 SLEEP APNOEA SYNDROME 215 0.0113
127 RALES 65 0.0112
128 BLOOD PRESSURE INADEQUATELY CONTROLLED 67 0.0111
129 VASCULITIS 126 0.0108
130 EOSINOPHIL COUNT INCREASED 90 0.0108
131 DERMATITIS CONTACT 123 0.0108
132 HYPERCHOLESTEROLAEMIA 104 0.0108
133 RESPIRATORY TRACT INFECTION VIRAL 25 0.0107
134 ADRENAL INSUFFICIENCY 130 0.0107
135 FOLLICULITIS 112 0.0107
136 IRON DEFICIENCY 48 0.0107
137 CYSTIC FIBROSIS 59 0.0106
138 INCREASED BRONCHIAL SECRETION 27 0.0105
139 GROWTH RETARDATION 31 0.0105
140 PRODUCTIVE COUGH 500 0.0105
141 PARAESTHESIA ORAL 151 0.0105
142 LIP DRY 95 0.0104
143 EXOSTOSIS 95 0.0104
144 EMPHYSEMA 103 0.0102
145 NAIL DISORDER 89 0.0102
146 HYPERVOLAEMIA 50 0.0101
147 SINUS DISORDER 200 0.0101
148 FACIAL PAIN 90 0.0101
149 SNORING 38 0.0100
150 SWOLLEN JOINT COUNT INCREASED 32 0.0100
151 MUSCLE INJURY 83 0.0100
152 PERICARDITIS 168 0.0100
153 ABDOMINAL RIGIDITY 27 0.0099
154 BRONCHIECTASIS 67 0.0099
155 INCORRECT DRUG ADMINISTRATION RATE 42 0.0099
156 SPUTUM DISCOLOURED 93 0.0098
157 EAR INFECTION 260 0.0098
158 BREATH SOUNDS ABNORMAL 48 0.0097
159 VAGINAL DISCHARGE 98 0.0097
160 NORMOCHROMIC NORMOCYTIC ANAEMIA 29 0.0096
161 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 163 0.0096
162 OBSTRUCTION 38 0.0095
163 SINUSITIS 973 0.0095
164 INSURANCE ISSUE 145 0.0095
165 HELICOBACTER INFECTION 97 0.0094
166 OBESITY 150 0.0094
167 DYSPNOEA EXERTIONAL 354 0.0094
168 SUSPECTED COVID-19 31 0.0094
169 SKIN ABRASION 44 0.0093
170 CONTRAINDICATED PRODUCT ADMINISTERED 280 0.0092
171 INFUSION RELATED REACTION 587 0.0088
172 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 48 0.0088
173 VASCULAR DEVICE INFECTION 40 0.0088
174 SINUS HEADACHE 52 0.0087
175 BLOOD URIC ACID INCREASED 50 0.0087
176 JOINT RANGE OF MOTION DECREASED 116 0.0086
177 INFUSION SITE EXTRAVASATION 53 0.0085
178 ORTHOPNOEA 27 0.0085
179 SECRETION DISCHARGE 106 0.0085
180 FIBROMYALGIA 205 0.0084
181 PEMPHIGUS 105 0.0084
182 NASAL CONGESTION 479 0.0081
183 SINUS CONGESTION 109 0.0081
184 RESPIRATORY TRACT CONGESTION 126 0.0079
185 TASTE DISORDER 160 0.0079
186 TRICUSPID VALVE INCOMPETENCE 62 0.0078
187 CANDIDIASIS 31 0.0077
188 HAEMOGLOBIN INCREASED 35 0.0077
189 EOSINOPHILIC PNEUMONIA 24 0.0076
190 DEAFNESS NEUROSENSORY 25 0.0076
191 DIVERTICULUM 54 0.0076
192 PARANASAL SINUS HYPERSECRETION 29 0.0076
193 VITAMIN D DEFICIENCY 74 0.0076
194 NEPHROGENIC ANAEMIA 35 0.0075
195 MYASTHENIA GRAVIS 61 0.0075
196 BRONCHOSPASM 107 0.0075
197 IRRITABLE BOWEL SYNDROME 160 0.0075
198 EAR DISCOMFORT 76 0.0074
199 IRON DEFICIENCY ANAEMIA 68 0.0074
200 FOREIGN BODY IN THROAT 23 0.0073
201 RHINOVIRUS INFECTION 28 0.0072
202 BRONCHITIS 524 0.0071
203 PRODUCT COMPLAINT 179 0.0071
204 GASTROOESOPHAGEAL REFLUX DISEASE 567 0.0070
205 PRODUCT DISTRIBUTION ISSUE 65 0.0070
206 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 119 0.0069
207 HORDEOLUM 30 0.0069
208 ENURESIS 28 0.0069
209 FLUID RETENTION 352 0.0069
210 CHOKING SENSATION 38 0.0069
211 LIGAMENT SPRAIN 68 0.0069
212 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 489 0.0069
213 PROCEDURAL PAIN 189 0.0068
214 RASH ERYTHEMATOUS 325 0.0068
215 EAR PAIN 132 0.0068
216 OROPHARYNGEAL DISCOMFORT 61 0.0067
217 SYNOVITIS 121 0.0067
218 SENSATION OF FOREIGN BODY 56 0.0066
219 HYPOPHOSPHATAEMIA 49 0.0066
220 TOOTH ABSCESS 67 0.0066
221 COUGH 1805 0.0064
222 OSTEOARTHRITIS 272 0.0064
223 EXPOSURE DURING PREGNANCY 395 0.0063
224 ARTHROPOD BITE 47 0.0063
225 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 329 0.0063
226 RHINORRHOEA 404 0.0062
227 SOMNAMBULISM 41 0.0062
228 CANDIDA INFECTION 105 0.0062
229 EPISTAXIS 465 0.0062
230 DYSPHONIA 363 0.0062
231 RESPIRATORY SYNCYTIAL VIRUS INFECTION 54 0.0062
232 ODYNOPHAGIA 37 0.0062
233 HEPATIC ENZYME INCREASED 422 0.0062
234 COVID-19 PNEUMONIA 73 0.0062
235 HIATUS HERNIA 80 0.0062
236 ONYCHOMYCOSIS 27 0.0061
237 APPENDICITIS 57 0.0061
238 PULMONARY FIBROSIS 117 0.0061
239 PAROSMIA 46 0.0061
240 HAEMOPTYSIS 168 0.0060
241 GASTROENTERITIS VIRAL 108 0.0060
242 BACTERIAL INFECTION 111 0.0059
243 HYPERLIPIDAEMIA 70 0.0059
244 GLOSSODYNIA 131 0.0058
245 PHARYNGITIS STREPTOCOCCAL 63 0.0058
246 POLYP 38 0.0058
247 SNEEZING 130 0.0058
248 ROSACEA 27 0.0058
249 ARTERIOSCLEROSIS CORONARY ARTERY 38 0.0057
250 APHONIA 80 0.0057
251 HAND DEFORMITY 75 0.0057
252 FREQUENT BOWEL MOVEMENTS 154 0.0057
253 MUSCLE STRAIN 49 0.0057
254 DECREASED ACTIVITY 61 0.0056
255 OEDEMA 306 0.0056
256 VIRAL INFECTION 187 0.0056
257 EYE INFECTION 63 0.0056
258 UMBILICAL HERNIA 26 0.0056
259 OXYGEN SATURATION DECREASED 312 0.0055
260 WEIGHT FLUCTUATION 58 0.0055
261 RHEUMATOID FACTOR POSITIVE 32 0.0055
262 NORMAL NEWBORN 30 0.0055
263 DECREASED IMMUNE RESPONSIVENESS 54 0.0055
264 PULMONARY FUNCTION TEST DECREASED 24 0.0055
265 HYPOXIA 192 0.0054
266 EYE PAIN 307 0.0054
267 NECK PAIN 304 0.0054
268 DRUG INTOLERANCE 525 0.0054
269 GLUCOSE TOLERANCE IMPAIRED 32 0.0054
270 FUNGAL INFECTION 179 0.0054
271 LUNG DISORDER 263 0.0054
272 PSEUDOMONAS INFECTION 46 0.0054
273 MUSCULOSKELETAL CHEST PAIN 83 0.0054
274 LOWER RESPIRATORY TRACT INFECTION 243 0.0053
275 NIGHT SWEATS 172 0.0053
276 BLOOD MAGNESIUM DECREASED 46 0.0053
277 TOOTH INFECTION 70 0.0053
278 OCULAR DISCOMFORT 59 0.0053
279 PNEUMOTHORAX 83 0.0052
280 PNEUMONIA BACTERIAL 48 0.0052
281 SKIN ATROPHY 30 0.0052
282 AGEUSIA 130 0.0052
283 ARTERIOSCLEROSIS 49 0.0052
284 HYSTERECTOMY 45 0.0052
285 WOUND 145 0.0052
286 RASH VESICULAR 25 0.0052
287 BRAIN FOG 81 0.0052
288 PRODUCT DOSE OMISSION ISSUE 1518 0.0052
289 RETCHING 110 0.0052
290 SLEEP DISORDER 364 0.0052
291 RED BLOOD CELL SEDIMENTATION RATE INCREASED 57 0.0051
292 HEREDITARY ANGIOEDEMA 55 0.0051
293 GRIP STRENGTH DECREASED 45 0.0051
294 SWELLING OF EYELID 32 0.0051
295 MIDDLE INSOMNIA 95 0.0051
296 SKIN INFECTION 57 0.0051
297 INTERVERTEBRAL DISC DEGENERATION 47 0.0051
298 NEUROLOGICAL SYMPTOM 29 0.0051
299 INTENTIONAL PRODUCT MISUSE 444 0.0051
300 TYPE 2 DIABETES MELLITUS 170 0.0050
301 ORAL DISORDER 37 0.0050
302 BENIGN PROSTATIC HYPERPLASIA 26 0.0050
303 PULMONARY MASS 75 0.0050
304 INJECTION SITE DISCHARGE 27 0.0050
305 SUBARACHNOID HAEMORRHAGE 51 0.0050
306 MALNUTRITION 56 0.0050
307 NEURALGIA 121 0.0050
308 PRODUCT ODOUR ABNORMAL 52 0.0050
309 BLOOD CHOLESTEROL INCREASED 231 0.0050
310 PERIORBITAL SWELLING 28 0.0049
311 LIVER FUNCTION TEST INCREASED 106 0.0049
312 RESPIRATION ABNORMAL 34 0.0049
313 AUTOIMMUNE DISORDER 48 0.0049
314 MIGRAINE 470 0.0049
315 TENDERNESS 51 0.0049
316 THROAT IRRITATION 219 0.0049
317 EPILEPSY 149 0.0049
318 OROPHARYNGEAL PAIN 451 0.0049
319 GASTROINTESTINAL MOTILITY DISORDER 26 0.0049
320 CHOLECYSTITIS CHRONIC 32 0.0048
321 PULMONARY CONGESTION 63 0.0048
322 POST-TRAUMATIC STRESS DISORDER 32 0.0048
323 GAIT INABILITY 159 0.0048
324 JOINT SWELLING 574 0.0048
325 NODULE 62 0.0047
326 ROTATOR CUFF SYNDROME 61 0.0047
327 RESPIRATORY DISORDER 142 0.0047
328 POOR VENOUS ACCESS 49 0.0047
329 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 227 0.0047
330 LIMB INJURY 128 0.0047
331 ILLNESS 485 0.0047
332 OSTEOPENIA 71 0.0047
333 SWOLLEN TONGUE 146 0.0047
334 WRIST FRACTURE 56 0.0047
335 OSTEOPOROSIS 192 0.0047
336 DIZZINESS POSTURAL 45 0.0046
337 STOMATITIS 281 0.0046
338 GOUT 83 0.0046
339 DRY THROAT 47 0.0046
340 DIPLOPIA 120 0.0046
341 RESTLESS LEGS SYNDROME 84 0.0046
342 VITAMIN D DECREASED 39 0.0046
343 INFECTION 660 0.0046
344 PNEUMONIA 1476 0.0046
345 EYE PRURITUS 153 0.0045
346 IMPAIRED GASTRIC EMPTYING 62 0.0045
347 CHEST DISCOMFORT 465 0.0045
348 PRODUCT USE ISSUE 852 0.0045
349 VENTRICULAR FIBRILLATION 50 0.0045
350 SKIN SWELLING 39 0.0045
351 STREPTOCOCCAL INFECTION 25 0.0045
352 ECONOMIC PROBLEM 68 0.0045
353 COVID-19 787 0.0045
354 LYMPHOEDEMA 31 0.0045
355 HYPERSENSITIVITY 832 0.0045
356 BLOOD IRON DECREASED 53 0.0045
357 HYPOVOLAEMIA 26 0.0044
358 FOOT FRACTURE 84 0.0044
359 EYE DISCHARGE 46 0.0044
360 NASOPHARYNGITIS 816 0.0044
361 DYSPNOEA 2501 0.0044
362 DUODENAL ULCER 31 0.0044
363 CONCUSSION 34 0.0044
364 TEMPERATURE INTOLERANCE 45 0.0044
365 RHEUMATOID ARTHRITIS 495 0.0044
366 CARPAL TUNNEL SYNDROME 61 0.0044
367 EYE HAEMORRHAGE 58 0.0043
368 PSORIATIC ARTHROPATHY 176 0.0043
369 SPINAL OSTEOARTHRITIS 38 0.0043
370 IMPAIRED HEALING 142 0.0043
371 DRY MOUTH 350 0.0043
372 HYPERTENSION 912 0.0043
373 PANIC REACTION 31 0.0043
374 HYPERHIDROSIS 553 0.0043
375 PULMONARY ALVEOLAR HAEMORRHAGE 24 0.0043
376 DIVERTICULITIS 118 0.0043
377 TREATMENT FAILURE 352 0.0042
378 ATELECTASIS 41 0.0042
379 GASTROINTESTINAL INFECTION 38 0.0042
380 RECTAL HAEMORRHAGE 182 0.0042
381 HAND FRACTURE 30 0.0042
382 C-REACTIVE PROTEIN INCREASED 154 0.0042
383 SKIN LACERATION 46 0.0042
384 SCAB 48 0.0042
385 PHARYNGITIS 52 0.0042
386 IMPAIRED QUALITY OF LIFE 60 0.0042
387 EOSINOPHILIA 73 0.0042
388 THYROID DISORDER 64 0.0041
389 CONTUSION 398 0.0041
390 INCREASED TENDENCY TO BRUISE 38 0.0041
391 BLADDER DISORDER 41 0.0041
392 ECZEMA 216 0.0041
393 NOCTURIA 50 0.0041
394 BODY HEIGHT DECREASED 44 0.0041
395 BLOOD COUNT ABNORMAL 62 0.0041
396 INFLAMMATION 211 0.0041
397 PHARYNGEAL SWELLING 40 0.0041
398 SYSTEMIC LUPUS ERYTHEMATOSUS 145 0.0041
399 APPETITE DISORDER 27 0.0041
400 DIABETES MELLITUS INADEQUATE CONTROL 72 0.0041
401 FLANK PAIN 38 0.0040
402 PHARMACEUTICAL PRODUCT COMPLAINT 105 0.0040
403 THERAPEUTIC PRODUCT EFFECT DECREASED 180 0.0040
404 INFLUENZA 448 0.0040
405 SPINAL COMPRESSION FRACTURE 33 0.0040
406 DYSPEPSIA 392 0.0040
407 ARTHRITIS 313 0.0040
408 MAJOR DEPRESSION 29 0.0040
409 TINNITUS 182 0.0040
410 LOWER LIMB FRACTURE 76 0.0040
411 BLISTER 222 0.0039
412 SCIATICA 63 0.0039
413 SENSITIVE SKIN 29 0.0039
414 PERIPHERAL SWELLING 605 0.0039
415 CARDIOGENIC SHOCK 56 0.0039
416 CHRONIC KIDNEY DISEASE 296 0.0039
417 PERICARDIAL EFFUSION 90 0.0039
418 COLITIS 146 0.0038
419 ACUTE RESPIRATORY FAILURE 74 0.0038
420 ORAL PAIN 86 0.0038
421 AFFECTIVE DISORDER 30 0.0038
422 BACK DISORDER 62 0.0038
423 INTERVERTEBRAL DISC PROTRUSION 83 0.0038
424 PULMONARY HYPERTENSION 79 0.0038
425 JOINT INJURY 81 0.0038
426 GLAUCOMA 73 0.0038
427 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 177 0.0038
428 LIVER INJURY 93 0.0038
429 AMNESIA 246 0.0038
430 ARTHROPATHY 210 0.0038
431 COGNITIVE DISORDER 176 0.0038
432 FOREIGN BODY SENSATION IN EYES 24 0.0038
433 CHEST PAIN 697 0.0038
434 URINARY TRACT INFECTION 641 0.0038
435 HEADACHE 2353 0.0037
436 CONSTIPATION 816 0.0037
437 C-REACTIVE PROTEIN ABNORMAL 24 0.0037
438 SWELLING 350 0.0037
439 ANGIOEDEMA 165 0.0037
440 HEAD DISCOMFORT 66 0.0037
441 LIP SWELLING 123 0.0037
442 BLOOD POTASSIUM DECREASED 111 0.0037
443 NERVE COMPRESSION 34 0.0037
444 LOCALISED INFECTION 89 0.0037
445 CYSTITIS 117 0.0037
446 RECALLED PRODUCT ADMINISTERED 35 0.0037
447 PULMONARY ARTERIAL HYPERTENSION 53 0.0037
448 HICCUPS 30 0.0037
449 SPINAL OPERATION 45 0.0036
450 OEDEMA PERIPHERAL 445 0.0036
451 FEEDING DISORDER 74 0.0036
452 TRANSIENT ISCHAEMIC ATTACK 123 0.0036
453 GALLBLADDER DISORDER 65 0.0036
454 HAEMORRHOIDS 71 0.0036
455 END STAGE RENAL DISEASE 66 0.0036
456 MUSCULAR WEAKNESS 410 0.0036
457 ATRIAL FIBRILLATION 351 0.0036
458 INTENTIONAL DOSE OMISSION 102 0.0036
459 VENTRICULAR TACHYCARDIA 59 0.0036
460 WEIGHT DECREASED 996 0.0036
461 POST PROCEDURAL INFECTION 29 0.0036
462 KNEE ARTHROPLASTY 75 0.0036
463 ABDOMINAL DISCOMFORT 597 0.0036
464 TROPONIN INCREASED 27 0.0035
465 ULCER HAEMORRHAGE 24 0.0035
466 LACRIMATION INCREASED 107 0.0035
467 CELLULITIS 178 0.0035
468 ESCHERICHIA INFECTION 29 0.0035
469 BLOOD PRESSURE ABNORMAL 70 0.0035
470 ULCER 56 0.0035
471 BACK PAIN 815 0.0035
472 CHOLECYSTECTOMY 40 0.0035
473 OBSESSIVE-COMPULSIVE DISORDER 28 0.0035
474 ANKLE FRACTURE 54 0.0035
475 POOR QUALITY SLEEP 75 0.0035
476 TENDON RUPTURE 43 0.0035
477 MUSCULOSKELETAL PAIN 182 0.0035
478 MYOPATHY 30 0.0035
479 DRY EYE 173 0.0035
480 HEART RATE INCREASED 343 0.0035
481 NEPHROLITHIASIS 158 0.0034
482 HEAD INJURY 109 0.0034
483 PULMONARY OEDEMA 154 0.0034
484 MOBILITY DECREASED 246 0.0034
485 INITIAL INSOMNIA 35 0.0034
486 RENAL CYST 27 0.0034
487 CONJUNCTIVITIS 63 0.0034
488 GINGIVAL PAIN 27 0.0034
489 SINUS TACHYCARDIA 48 0.0034
490 SPINAL DISORDER 32 0.0034
491 CORONARY ARTERY DISEASE 102 0.0034
492 HEART RATE IRREGULAR 76 0.0034
493 ANHEDONIA 88 0.0033
494 DEPRESSED MOOD 177 0.0033
495 URINARY INCONTINENCE 99 0.0033
496 MUSCLE TWITCHING 77 0.0033
497 THROAT TIGHTNESS 90 0.0033
498 CATARACT 198 0.0033
499 TONGUE DISORDER 24 0.0033
500 PRODUCT ADMINISTRATION ERROR 67 0.0033
501 HYPERSOMNIA 95 0.0033
502 RIB FRACTURE 68 0.0033
503 POST PROCEDURAL COMPLICATION 63 0.0033
504 PYREXIA 1133 0.0033
505 HYPOAESTHESIA 489 0.0033
506 PALPITATIONS 381 0.0032
507 UROSEPSIS 30 0.0032
508 PRODUCT DOSE OMISSION IN ERROR 92 0.0032
509 MEMORY IMPAIRMENT 446 0.0032
510 BREAST CANCER STAGE II 27 0.0032
511 PHOTOPHOBIA 61 0.0032
512 CARDIAC MURMUR 28 0.0032
513 PULMONARY EMBOLISM 307 0.0032
514 LYMPHADENOPATHY 114 0.0032
515 INTENTIONAL PRODUCT USE ISSUE 282 0.0032
516 INCONTINENCE 34 0.0032
517 SURGERY 188 0.0032
518 ABDOMINAL PAIN UPPER 657 0.0032
519 INJURY 224 0.0032
520 FULL BLOOD COUNT DECREASED 64 0.0032
521 PETECHIAE 33 0.0032
522 HERNIA 61 0.0032
523 VITREOUS FLOATERS 31 0.0032
524 ANXIETY 895 0.0031
525 ATRIAL FLUTTER 25 0.0031
526 DISEASE RECURRENCE 149 0.0031
527 BLOOD TEST ABNORMAL 44 0.0031
528 EYE IRRITATION 180 0.0031
529 JOINT DISLOCATION 33 0.0031
530 PULMONARY THROMBOSIS 34 0.0031
531 PAIN 1915 0.0031
532 MUSCLE SPASMS 571 0.0031
533 HAEMATOCHEZIA 171 0.0031
534 BASAL CELL CARCINOMA 48 0.0031
535 SKIN FISSURES 60 0.0031
536 PRODUCT PRESCRIBING ERROR 73 0.0031
537 MICTURITION URGENCY 35 0.0031
538 PERIPHERAL COLDNESS 42 0.0031
539 DERMATITIS ATOPIC 161 0.0031
540 WEIGHT INCREASED 681 0.0030
541 TACHYCARDIA 269 0.0030
542 BLOOD ALBUMIN DECREASED 24 0.0030
543 BLOOD CALCIUM DECREASED 34 0.0030
544 PRODUCT USE IN UNAPPROVED INDICATION 749 0.0030
545 MUSCULOSKELETAL DISCOMFORT 52 0.0030
546 MYOCLONUS 36 0.0030
547 DEHYDRATION 402 0.0030
548 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 541 0.0030
549 HYPONATRAEMIA 169 0.0030
550 GASTROINTESTINAL PAIN 33 0.0030
551 OCULAR HYPERAEMIA 142 0.0030
552 SKIN LESION 82 0.0030
553 THROMBOCYTOPENIA 332 0.0030
554 SWELLING FACE 193 0.0030
555 BLOOD PRESSURE INCREASED 453 0.0030
556 HEPATIC STEATOSIS 55 0.0029
557 HUNGER 41 0.0029
558 ABDOMINAL DISTENSION 307 0.0029
559 SCRATCH 31 0.0029
560 CONDITION AGGRAVATED 893 0.0029
561 RESPIRATORY DISTRESS 81 0.0029
562 DYSURIA 108 0.0029
563 POLYURIA 24 0.0029
564 DISTURBANCE IN ATTENTION 158 0.0029
565 POLLAKIURIA 122 0.0029
566 PAIN IN EXTREMITY 859 0.0029
567 CARDIOMYOPATHY 43 0.0029
568 MALAISE 1275 0.0029
569 PARAESTHESIA 457 0.0029
570 DRUG EFFECT LESS THAN EXPECTED 43 0.0029
571 NEUROPATHY PERIPHERAL 276 0.0029
572 SKIN HAEMORRHAGE 43 0.0029
573 THROMBOSIS 233 0.0029
574 FOOT DEFORMITY 32 0.0029
575 COLITIS ULCERATIVE 129 0.0029
576 FALL 960 0.0029
577 DIZZINESS 1435 0.0029
578 ERYTHEMA 591 0.0029
579 VERTIGO 175 0.0029
580 SQUAMOUS CELL CARCINOMA 27 0.0029
581 BLOOD SODIUM DECREASED 54 0.0029
582 DEEP VEIN THROMBOSIS 186 0.0029
583 UPPER LIMB FRACTURE 57 0.0029
584 PRODUCT USE COMPLAINT 45 0.0029
585 THIRST 51 0.0029
586 STAPHYLOCOCCAL INFECTION 94 0.0028
587 KNEE OPERATION 28 0.0028
588 CARDIOMEGALY 35 0.0028
589 SLUGGISHNESS 29 0.0028
590 OESOPHAGITIS 31 0.0028
591 HOSPICE CARE 28 0.0028
592 BLOOD PRESSURE FLUCTUATION 68 0.0028
593 THERAPEUTIC RESPONSE UNEXPECTED 127 0.0028
594 DEAFNESS 74 0.0028
595 THERAPY NON-RESPONDER 127 0.0028
596 PAIN IN JAW 80 0.0028
597 RASH PRURITIC 153 0.0028
598 HYPOTHYROIDISM 90 0.0028
599 ORAL HERPES 55 0.0028
600 ORAL DISCOMFORT 39 0.0028
601 KIDNEY INFECTION 55 0.0028
602 DENTAL CARIES 31 0.0028
603 FATIGUE 2174 0.0028
604 ASCITES 82 0.0028
605 JOINT STIFFNESS 73 0.0028
606 MATERNAL EXPOSURE DURING PREGNANCY 248 0.0028
607 RASH 1210 0.0028
608 CHOKING 54 0.0028
609 MUSCLE ATROPHY 35 0.0028
610 DEVICE FAILURE 42 0.0028
611 ORTHOSTATIC HYPOTENSION 48 0.0028
612 HERPES ZOSTER 158 0.0027
613 DEPRESSION 625 0.0027
614 GASTROINTESTINAL DISORDER 246 0.0027
615 HIP ARTHROPLASTY 42 0.0027
616 CYST 34 0.0027
617 ARTHRALGIA 1137 0.0027
618 URTICARIA 458 0.0027
619 PHOTOSENSITIVITY REACTION 45 0.0027
620 IMMUNOSUPPRESSION 24 0.0027
621 PANIC ATTACK 99 0.0027
622 LUNG INFECTION 42 0.0027
623 PRURITUS 1038 0.0027
624 NIGHTMARE 93 0.0027
625 LIVER FUNCTION TEST ABNORMAL 78 0.0027
626 CARDIAC FAILURE CONGESTIVE 214 0.0027
627 EXPOSURE VIA SKIN CONTACT 69 0.0027
628 LEUKOCYTOSIS 48 0.0026
629 TREATMENT NONCOMPLIANCE 145 0.0026
630 VOMITING 1241 0.0026
631 BALANCE DISORDER 228 0.0026
632 BLOOD CALCIUM INCREASED 23 0.0026
633 CHOLELITHIASIS 86 0.0026
634 BLOOD ALKALINE PHOSPHATASE INCREASED 65 0.0026
635 DYSSTASIA 76 0.0026
636 SMALL INTESTINAL OBSTRUCTION 32 0.0026
637 PAIN OF SKIN 70 0.0026
638 HALLUCINATION 195 0.0026
639 BLOOD POTASSIUM INCREASED 42 0.0026
640 DIARRHOEA 1669 0.0026
641 DRUG INTERACTION 410 0.0026
642 TENDONITIS 40 0.0026
643 FEELING ABNORMAL 619 0.0026
644 BLOOD URINE PRESENT 49 0.0026
645 EYE SWELLING 96 0.0026
646 DISABILITY 51 0.0026
647 FEELING HOT 158 0.0026
648 ASTHENIA 968 0.0026
649 VISION BLURRED 352 0.0026
650 TOOTH DISORDER 57 0.0026
651 ROAD TRAFFIC ACCIDENT 107 0.0026
652 ANAL INCONTINENCE 23 0.0026
653 COMPLICATION ASSOCIATED WITH DEVICE 37 0.0025
654 PSORIASIS 332 0.0025
655 PSYCHOMOTOR HYPERACTIVITY 42 0.0025
656 NERVE INJURY 28 0.0025
657 INSOMNIA 670 0.0025
658 CONFUSIONAL STATE 406 0.0025
659 SCAR 43 0.0025
660 PRESYNCOPE 61 0.0025
661 GASTRITIS 66 0.0025
662 HEART RATE DECREASED 88 0.0025
663 IMMUNE SYSTEM DISORDER 33 0.0025
664 WHITE BLOOD CELL COUNT INCREASED 96 0.0025
665 DISCOMFORT 152 0.0025
666 EATING DISORDER 53 0.0025
667 RASH MACULAR 87 0.0025
668 DEVICE OCCLUSION 35 0.0025
669 GENERAL PHYSICAL HEALTH DETERIORATION 287 0.0025
670 MUSCLE TIGHTNESS 40 0.0025
671 ASPIRATION 27 0.0025
672 PLEURAL EFFUSION 150 0.0025
673 LIMB DISCOMFORT 76 0.0025
674 HYPOAESTHESIA ORAL 37 0.0025
675 PRODUCT QUALITY ISSUE 333 0.0024
676 TOOTH FRACTURE 27 0.0024
677 SPINAL FRACTURE 49 0.0024
678 THERAPEUTIC RESPONSE DECREASED 148 0.0024
679 HYPOACUSIS 105 0.0024
680 SEPSIS 272 0.0024
681 DRY SKIN 325 0.0024
682 HAEMATOMA 63 0.0024
683 INFLUENZA LIKE ILLNESS 200 0.0024
684 VISUAL IMPAIRMENT 301 0.0024
685 ACCIDENT 29 0.0024
686 HYPOKALAEMIA 112 0.0024
687 HAEMATOCRIT DECREASED 48 0.0024
688 MYALGIA 410 0.0024
689 PHARYNGEAL OEDEMA 37 0.0024
690 PRODUCT DOSE OMISSION 157 0.0024
691 DYSPHAGIA 228 0.0024
692 SOMNOLENCE 483 0.0024
693 LETHARGY 138 0.0024
694 ABDOMINAL PAIN 557 0.0024
695 BLOOD UREA INCREASED 40 0.0024
696 DIABETES MELLITUS 182 0.0024
697 NAUSEA 1880 0.0024
698 EYE DISORDER 78 0.0024
699 RESPIRATORY DEPRESSION 29 0.0024
700 RASH PAPULAR 53 0.0024
701 CARDIAC DISORDER 221 0.0024
702 HEPATIC CIRRHOSIS 44 0.0023
703 COAGULOPATHY 39 0.0023
704 HEPATOMEGALY 23 0.0023
705 SKIN DISORDER 78 0.0023
706 ERECTILE DYSFUNCTION 60 0.0023
707 BLOOD PRESSURE DECREASED 154 0.0023
708 MUSCULOSKELETAL STIFFNESS 203 0.0023
709 ANAEMIA 441 0.0023
710 CHILLS 271 0.0023
711 FLATULENCE 131 0.0023
712 FEELING JITTERY 44 0.0023
713 SKIN DISCOLOURATION 106 0.0023
714 BODY TEMPERATURE INCREASED 47 0.0023
715 PLATELET COUNT INCREASED 30 0.0023
716 MITRAL VALVE INCOMPETENCE 26 0.0023
717 ACCIDENTAL UNDERDOSE 33 0.0023
718 CLOSTRIDIUM DIFFICILE INFECTION 50 0.0023
719 SKIN ULCER 59 0.0023
720 INJECTION SITE IRRITATION 29 0.0023
721 LABORATORY TEST ABNORMAL 67 0.0023
722 CHOLECYSTITIS 27 0.0023
723 RENAL PAIN 24 0.0023
724 FLUSHING 230 0.0023
725 MULTIPLE ORGAN DYSFUNCTION SYNDROME 64 0.0023
726 TREMOR 375 0.0023
727 THINKING ABNORMAL 42 0.0023
728 DEVICE DEFECTIVE 39 0.0022
729 PRODUCT PRESCRIBING ISSUE 49 0.0022
730 HOSPITALISATION 345 0.0022
731 DERMATITIS 47 0.0022
732 ELECTROLYTE IMBALANCE 26 0.0022
733 COORDINATION ABNORMAL 31 0.0022
734 OFF LABEL USE 1942 0.0022
735 RENAL DISORDER 103 0.0022
736 SARS-COV-2 TEST POSITIVE 29 0.0022
737 DYSGEUSIA 163 0.0022
738 RENAL FAILURE 289 0.0022
739 DEVICE USE ISSUE 38 0.0022
740 INCORRECT PRODUCT ADMINISTRATION DURATION 47 0.0022
741 TOOTH EXTRACTION 27 0.0022
742 RED BLOOD CELL COUNT DECREASED 62 0.0022
743 EXPIRED PRODUCT ADMINISTERED 72 0.0022
744 MENTAL STATUS CHANGES 60 0.0022
745 GASTRIC ULCER 41 0.0022
746 COLD SWEAT 38 0.0022
747 POST PROCEDURAL HAEMORRHAGE 25 0.0021
748 PRODUCT TASTE ABNORMAL 29 0.0021
749 DECREASED APPETITE 497 0.0021
750 SYNCOPE 214 0.0021
751 HYPOTENSION 428 0.0021
752 GASTROENTERITIS 31 0.0021
753 IRRITABILITY 127 0.0021
754 SKIN EXFOLIATION 178 0.0021
755 MYOCARDIAL ISCHAEMIA 24 0.0021
756 PRESCRIBED UNDERDOSE 42 0.0021
757 MEDICATION ERROR 117 0.0021
758 ANAPHYLACTIC REACTION 116 0.0021
759 CYANOSIS 33 0.0021
760 ANOREXIA 27 0.0021
761 GAIT DISTURBANCE 399 0.0021
762 TACHYPNOEA 28 0.0021
763 MOOD ALTERED 56 0.0021
764 OSTEOMYELITIS 37 0.0020
765 INTRAOCULAR PRESSURE INCREASED 26 0.0020
766 FAECES DISCOLOURED 44 0.0020
767 LOSS OF CONSCIOUSNESS 260 0.0020
768 BACTERAEMIA 24 0.0020
769 UPPER GASTROINTESTINAL HAEMORRHAGE 34 0.0020
770 BLINDNESS 82 0.0020
771 ABSCESS 32 0.0020
772 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 110 0.0020
773 PNEUMONIA ASPIRATION 50 0.0020
774 SPEECH DISORDER 103 0.0020
775 INJECTION SITE SWELLING 150 0.0020
776 ENCEPHALOPATHY 48 0.0020
777 GLOMERULAR FILTRATION RATE DECREASED 24 0.0020
778 MOUTH ULCERATION 41 0.0019
779 WHITE BLOOD CELL COUNT DECREASED 210 0.0019
780 HOT FLUSH 146 0.0019
781 TOOTHACHE 35 0.0019
782 MASS 27 0.0019
783 THERAPY PARTIAL RESPONDER 30 0.0019
784 RESPIRATORY FAILURE 140 0.0019
785 DISORIENTATION 76 0.0019
786 FEMUR FRACTURE 59 0.0019
787 BURNING SENSATION 133 0.0019
788 SEIZURE 219 0.0019
789 NEEDLE ISSUE 55 0.0019
790 THERAPY INTERRUPTED 135 0.0019
791 ALOPECIA 370 0.0019
792 COLON CANCER 28 0.0019
793 AGGRESSION 94 0.0019
794 HYPERGLYCAEMIA 68 0.0019
795 BONE DISORDER 34 0.0019
796 DRUG INEFFECTIVE 2456 0.0019
797 BONE PAIN 109 0.0019
798 APATHY 27 0.0018
799 GASTROINTESTINAL HAEMORRHAGE 153 0.0018
800 UNEVALUABLE EVENT 138 0.0018
801 GLYCOSYLATED HAEMOGLOBIN INCREASED 46 0.0018
802 NERVOUSNESS 95 0.0018
803 DELIRIUM 63 0.0018
804 ANGINA PECTORIS 52 0.0018
805 HAEMATEMESIS 46 0.0018
806 BLOOD TRIGLYCERIDES INCREASED 32 0.0018
807 THERAPEUTIC RESPONSE SHORTENED 60 0.0018
808 OVERDOSE 388 0.0018
809 URINARY RETENTION 60 0.0018
810 HYPERTHYROIDISM 26 0.0018
811 MUSCULOSKELETAL DISORDER 34 0.0018
812 INCREASED APPETITE 34 0.0018
813 ILL-DEFINED DISORDER 108 0.0018
814 ANGER 60 0.0018
815 LYMPHOPENIA 25 0.0018
816 APHASIA 53 0.0018
817 INTESTINAL OBSTRUCTION 66 0.0017
818 ASPARTATE AMINOTRANSFERASE INCREASED 93 0.0017
819 PARALYSIS 25 0.0017
820 INJECTION SITE PRURITUS 116 0.0017
821 ALANINE AMINOTRANSFERASE INCREASED 106 0.0017
822 ADVERSE DRUG REACTION 155 0.0017
823 HYPOPHAGIA 44 0.0017
824 BLOOD GLUCOSE DECREASED 82 0.0017
825 TUBULOINTERSTITIAL NEPHRITIS 32 0.0017
826 CRYING 62 0.0017
827 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 345 0.0017
828 BLINDNESS UNILATERAL 24 0.0017
829 RASH GENERALISED 44 0.0017
830 HAEMOGLOBIN DECREASED 174 0.0017
831 CARDIAC FAILURE 136 0.0017
832 DRUG ERUPTION 30 0.0017
833 DYSARTHRIA 63 0.0017
834 DEVICE USE ERROR 58 0.0017
835 PRODUCT SUBSTITUTION ISSUE 96 0.0017
836 MYELODYSPLASTIC SYNDROME 24 0.0017
837 ERUCTATION 32 0.0017
838 RENAL INJURY 49 0.0016
839 HIP FRACTURE 53 0.0016
840 LIVER DISORDER 73 0.0016
841 CIRCULATORY COLLAPSE 28 0.0016
842 HALLUCINATION, AUDITORY 26 0.0016
843 ACUTE KIDNEY INJURY 250 0.0016
844 BONE DENSITY DECREASED 51 0.0016
845 SENSORY DISTURBANCE 26 0.0016
846 RESTLESSNESS 59 0.0016
847 EJECTION FRACTION DECREASED 25 0.0016
848 INJECTION SITE RASH 49 0.0016
849 INJECTION SITE PAIN 489 0.0016
850 BLOOD PRESSURE SYSTOLIC INCREASED 31 0.0016
851 EMOTIONAL DISTRESS 192 0.0016
852 OSTEONECROSIS 52 0.0016
853 FLUID OVERLOAD 23 0.0016
854 AGITATION 116 0.0016
855 SKIN CANCER 34 0.0016
856 ABASIA 39 0.0016
857 BLOOD GLUCOSE ABNORMAL 29 0.0016
858 PARANOIA 27 0.0016
859 UNDERDOSE 114 0.0016
860 ACUTE MYOCARDIAL INFARCTION 46 0.0016
861 PRODUCT PREPARATION ERROR 32 0.0016
862 MOVEMENT DISORDER 50 0.0016
863 EMOTIONAL DISORDER 48 0.0016
864 INJECTION SITE ERYTHEMA 193 0.0016
865 RENAL FAILURE ACUTE 66 0.0016
866 FEELING COLD 43 0.0015
867 ABNORMAL BEHAVIOUR 61 0.0015
868 HEMIPARESIS 26 0.0015
869 BLOOD GLUCOSE INCREASED 289 0.0015
870 ACCIDENTAL OVERDOSE 56 0.0015
871 SUICIDAL IDEATION 139 0.0015
872 INJECTION SITE URTICARIA 37 0.0015
873 WITHDRAWAL SYNDROME 63 0.0015
874 PANCREATITIS 79 0.0015
875 DEVICE RELATED INFECTION 23 0.0015
876 INCORRECT DOSE ADMINISTERED 341 0.0015
877 HEPATIC FAILURE 45 0.0015
878 CONVULSION 85 0.0015
879 GASTRIC DISORDER 51 0.0015
880 MULTIPLE SCLEROSIS 71 0.0015
881 BLOOD BILIRUBIN INCREASED 40 0.0015
882 INTERNATIONAL NORMALISED RATIO INCREASED 42 0.0015
883 MULTIPLE FRACTURES 24 0.0015
884 ARRHYTHMIA 69 0.0015
885 PLATELET COUNT DECREASED 155 0.0015
886 FEAR 39 0.0014
887 ABNORMAL DREAMS 40 0.0014
888 HYPOGLYCAEMIA 70 0.0014
889 EXTRA DOSE ADMINISTERED 58 0.0014
890 FRACTURE 27 0.0014
891 HALLUCINATION, VISUAL 30 0.0014
892 INCORRECT DOSE ADMINISTERED BY DEVICE 37 0.0014
893 BLOOD CREATININE INCREASED 92 0.0014
894 INTERSTITIAL LUNG DISEASE 68 0.0014
895 IMPAIRED WORK ABILITY 30 0.0014
896 MENTAL DISORDER 61 0.0014
897 UNRESPONSIVE TO STIMULI 36 0.0014
898 DEVICE DELIVERY SYSTEM ISSUE 38 0.0014
899 CHROMATURIA 31 0.0014
900 DEMENTIA 38 0.0014
901 LEUKOPENIA 68 0.0014
902 PNEUMONITIS 37 0.0014
903 INJECTION SITE REACTION 92 0.0013
904 MYOCARDIAL INFARCTION 233 0.0013
905 HEPATITIS 34 0.0013
906 INJECTION SITE BRUISING 106 0.0013
907 DYSKINESIA 54 0.0013
908 PALLOR 36 0.0013
909 PSYCHOTIC DISORDER 39 0.0013
910 PRODUCT AVAILABILITY ISSUE 30 0.0013
911 RENAL IMPAIRMENT 110 0.0013
912 NEUTROPHIL COUNT DECREASED 53 0.0013
913 INJECTION SITE MASS 48 0.0013
914 PRURITUS GENERALISED 28 0.0013
915 DEVICE ISSUE 116 0.0013
916 HAEMATURIA 44 0.0013
917 HYPERKALAEMIA 45 0.0013
918 HAEMORRHAGE 134 0.0013
919 DRUG EFFECT DECREASED 69 0.0013
920 DEVICE DISLOCATION 55 0.0013
921 DRUG EXPOSURE DURING PREGNANCY 43 0.0013
922 TOOTH LOSS 26 0.0013
923 ACCIDENTAL EXPOSURE TO PRODUCT 126 0.0012
924 ACTIVITIES OF DAILY LIVING IMPAIRED 24 0.0012
925 DEVICE BREAKAGE 49 0.0012
926 DRUG ADMINISTRATION ERROR 37 0.0012
927 NEOPLASM MALIGNANT 80 0.0012
928 CEREBROVASCULAR ACCIDENT 203 0.0012
929 SEPTIC SHOCK 52 0.0012
930 PRODUCT DISPENSING ERROR 26 0.0012
931 MOOD SWINGS 38 0.0012
932 JAUNDICE 32 0.0012
933 SEDATION 31 0.0012
934 BLOOD CREATINE PHOSPHOKINASE INCREASED 34 0.0012
935 VISUAL ACUITY REDUCED 39 0.0012
936 DRUG EFFECT INCOMPLETE 42 0.0012
937 MENTAL IMPAIRMENT 28 0.0012
938 DEVICE LEAKAGE 50 0.0012
939 BRADYCARDIA 60 0.0011
940 ADVERSE EVENT 104 0.0011
941 STEVENS-JOHNSON SYNDROME 25 0.0011
942 ABDOMINAL PAIN LOWER 28 0.0011
943 THERAPY CESSATION 56 0.0011
944 DEPRESSED LEVEL OF CONSCIOUSNESS 43 0.0011
945 ELECTROCARDIOGRAM QT PROLONGED 39 0.0011
946 GAMMA-GLUTAMYLTRANSFERASE INCREASED 24 0.0011
947 MULTIPLE SCLEROSIS RELAPSE 74 0.0011
948 NERVOUS SYSTEM DISORDER 32 0.0010
949 FEBRILE NEUTROPENIA 68 0.0010
950 CEREBRAL HAEMORRHAGE 36 0.0010
951 ACNE 76 0.0010
952 NO ADVERSE EVENT 181 0.0010
953 LACTIC ACIDOSIS 32 0.0010
954 INCORRECT DRUG ADMINISTRATION DURATION 27 0.0010
955 DRUG-INDUCED LIVER INJURY 30 0.0010
956 DEVICE MALFUNCTION 67 0.0010
957 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 32 0.0009
958 RESPIRATORY ARREST 26 0.0009
959 CEREBRAL INFARCTION 23 0.0009
960 CARDIAC ARREST 77 0.0009
961 TARDIVE DYSKINESIA 26 0.0009
962 PRODUCT STORAGE ERROR 79 0.0009
963 INJECTION SITE HAEMORRHAGE 72 0.0009
964 ANAPHYLACTIC SHOCK 23 0.0009
965 NEUTROPENIA 121 0.0009
966 INCORRECT ROUTE OF DRUG ADMINISTRATION 31 0.0009
967 SKIN BURNING SENSATION 61 0.0009
968 DRUG DOSE OMISSION 140 0.0008
969 PANCYTOPENIA 47 0.0008
970 DRUG ABUSE 70 0.0008
971 SKIN IRRITATION 38 0.0008
972 DEATH 698 0.0008
973 DRUG DEPENDENCE 126 0.0008
974 LUNG NEOPLASM MALIGNANT 32 0.0008
975 PLASMA CELL MYELOMA 30 0.0008
976 RHABDOMYOLYSIS 31 0.0007
977 CARDIO-RESPIRATORY ARREST 31 0.0007
978 NEOPLASM PROGRESSION 25 0.0007
979 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 50 0.0007
980 HEPATIC FUNCTION ABNORMAL 26 0.0007
981 SUICIDE ATTEMPT 42 0.0007
982 DISEASE PROGRESSION 79 0.0007
983 COMA 29 0.0006
984 PROSTATE CANCER 47 0.0006
985 DEVICE DIFFICULT TO USE 37 0.0006
986 MALIGNANT NEOPLASM PROGRESSION 55 0.0005
987 BREAST CANCER 46 0.0005
988 FOETAL EXPOSURE DURING PREGNANCY 40 0.0005
989 DRUG WITHDRAWAL SYNDROME 42 0.0005
990 DRUG DOSE OMISSION BY DEVICE 29 0.0004
991 TOXICITY TO VARIOUS AGENTS 59 0.0003